ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstract Number: 99

PILOT STUDY MEASURING HEPCIDIN AND ARTERIAL STIFFNESS IN CHILDREN WITH SLE AND LUPUS NEPHRITIS

Sangeeta Sule1, Sarah Joo2 and Meredith Atkinson2, 1Pediatrics, Johns Hopkins University, Baltimore, MD, 2Johns Hopkins University, Baltimore, MD

Meeting: 2017 Pediatric Rheumatology Symposium

Keywords: Lupus nephritis

  • Tweet
  • Email
  • Print
Session Information

Date: Thursday, May 18, 2017

Session Title: Clinical and Therapeutic Poster Session

Session Type: Abstract Submissions

Session Time: 5:30PM-7:00PM

Background/Purpose:

Cardiovascular disease (CV dz) is common in SLE and lupus nephritis (LN), but premature atherosclerosis risk does not appear to be linked to classic CV risk factors like hypertension. Up to 80% of children with SLE develop kidney dz, which is also associated with increased risk for CV dz and death compared to those without renal involvement. Hepcidin (Hp) is an iron-regulatory protein which may contribute to atherosclerosis and is elevated in autoimmune dz. Pulse wave velocity (PWV) is a validated indicator of arterial stiffness, an early marker of CV risk, in children and is increased in children with SLE vs. healthy controls. Our objective was to quantify Hp and PWV in children with SLE and to determine if those with biopsy-proven lupus nephritis (LN) have higher Hp levels and higher PWV compared to those without kidney dz.

Methods:

Cross-sectional analysis with Hp measured via ELISA assay. Arterial stiffness quantified by carotid-femoral PWV. Pearson chi2/paired t testing or Wilcoxan rank sum test for comparison of proportions, means, or median.

Results:

The cohort (n=16) was 93.8% female and 68.8% black with mean (SD) age of 15.2 (3.6) yrs. 37.5% (n=6) had LN. Overall mean (SD) Hp was 53.9 (47.8) ng/mL, median (IQR) 34.4 (18.9, 91.9) ng/mL. Both Hepcidin levels and PWV were higher in the subjects with LN.

Nephritis (n=6)

No Nephritis (n=10)

p-value

Age (yrs)

16.5 (1.6)

14.5 (1.2)

0.32

% Black

100%

50%

0.23

Hepcidin, median (IQR)

71.55 (26.4, 116.4)

27.9 (18.7, 59.7)

0.19

Arterial Stiffness

On BP meds, % (n)

83.3% (5)

0% (0)

<0.001

SBP (mmHg)

121 (10.9)

111 (17.5)

0.26

DBP (mmHg)

67 (19.3)

62 (8.2)

0.34

PWV (m/s)

4.9 (0.95)

4.1 (0.47)

0.05

Conclusion:

In this pilot analysis, serum Hp and PWV were both elevated in subjects with LN compared to those with SLE alone. No significant differences in blood pressure, a traditional CV risk factor, were noted. This suggests Hp may be a mediator of morbid CV changes in LN and warrants further study.


Disclosure: S. Sule, None; S. Joo, None; M. Atkinson, None.

To cite this abstract in AMA style:

Sule S, Joo S, Atkinson M. PILOT STUDY MEASURING HEPCIDIN AND ARTERIAL STIFFNESS IN CHILDREN WITH SLE AND LUPUS NEPHRITIS [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 4). https://acrabstracts.org/abstract/pilot-study-measuring-hepcidin-and-arterial-stiffness-in-children-with-sle-and-lupus-nephritis/. Accessed February 4, 2023.
  • Tweet
  • Email
  • Print

« Back to 2017 Pediatric Rheumatology Symposium

ACR Meeting Abstracts - https://acrabstracts.org/abstract/pilot-study-measuring-hepcidin-and-arterial-stiffness-in-children-with-sle-and-lupus-nephritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2023 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences